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Abstract: We have developed an aptamer-based microarray for human thrombin detection 
exploiting two non-overlapping DNA thrombin aptamers recognizing different exosites of 
the target protein. The 15-mer aptamer (TBA1) binds the fibrinogen-binding site, whereas 
the 29-mer aptamer (TBA2) binds the heparin binding domain. Extensive analysis on the 
complex formation between human thrombin and modified aptamers was performed by 
Electrophoresis Mobility Shift Assay (EMSA), in order to verify in solution whether the 
chemical modifications introduced would affect aptamers/protein recognition. The validated 
system was then applied to the aptamer microarray, using the solid phase system devised 
by the solution studies. Finally, the best procedure for Sandwich Aptamer Microarray 
(SAM) and the specificity of the sandwich formation for the developed aptasensor for 
human thrombin were optimized. 
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Abbreviations 
Alexa  Alexa555
® fluorophore 
Cy5  Cyanine dye 
DMSO  Dimethyl sulfoxide 
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EMSA  Electrophoretic Mobility Shift Assay 
FBD  Fibrinogen Binding Domain 
G-4  G-quadruplex 
HBD  Heparin Binding Domain 
NAS  N,N-acryloyloxysuccinimide 
OTA  Ochratoxin A binding aptamer 
PAA   polyacrylamide 
PBS   Phosphate Buffered Saline 
SAM  Sandwich Aptamer Microarray 
SELEX  Systematic Evolution of Ligands by EXponential enrichment 
SDS  Sodium Dodecyl Sulfate 
TBA1  unmodified 15-mer Thrombin Binding Aptamer 1 
TBA1-NH2  5’-amino modified Thrombin Binding Aptamer 1 
TBA1(12T)NH2  5’-amino modified plus a polyT(12) spacer Thrombin Binding Aptamer 1 
TBA2  unmodified 29-mer Thrombin Binding Aptamer 2 
TBA2Cy5  5’-Cy5 modified Thrombin Binding Aptamer 2 
TBE  tris-borate-EDTA buffer 
Thr  Thrombin 
1. Introduction 
Aptamers are RNA or single stranded DNA molecules that selectively bind to various molecular 
targets, such as small molecules, proteins, nucleic acids, cells, or microorganisms [1,2]. They bind to 
molecular targets with high specificity and affinity, making them attractive alternatives to the 
commonly used antibodies. Aptamers are selected in vitro from a large oligonucleotides pool through a 
process called Systematic Evolution of Ligands by EXponential enrichment (SELEX) [3]. Besides 
lower production costs, added advantages over antibodies are their relative ease of isolation and 
modification, tailored binding affinity and reversible denaturation, making them suitable candidates for 
use as detection systems. When adapting aptamers to a defined solid phase and to a specific detection 
technique, appropriate and sometimes profound post-SELEX chemical modifications must be 
introduced. In the case of microarrays, immobilization to the solid support and labeling for detection 
imply precise chemistries, depending on the physical support and detection technique, that could 
sensibly alter the aptamer structure [4]. In fact, since aptamers are evolved in solution, any modification 
altering the chemical identity of aptamer could affect its folding and consequently its binding to the 
target: therefore, great care must be taken when developing aptamer-based detection methods in solid 
phase employing aptamers previously selected in solution. 
Thrombin, a protein involved in the blood coagulation cascade, was the first biological macromolecule 
exploited for aptamer selection [5]. Thrombin is a serine protease that plays an important role in 
thrombosis and hemostasis. It converts fibrinogen into clottable fibrin [6,7]. The concentration of 
thrombin in blood varies considerably, and can be almost absent in the blood of healthy subjects. 
However, it can reach low-micromolar concentrations during the coagulation process, and even low Sensors 2011, 11                  
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levels of thrombin can be generated in the early hemostatic process [8]. Consequently, aptamer-based 
assays for thrombin detection are possible diagnostic tools for monitoring the thrombin level in plasma 
or blood in the clinical area.  
Thrombin binding DNA-aptamers have been extensively investigated [9]. In particular, the 
thrombin binding aptamer 1 (TBA1) and 2 (TBA2) consist of two G-quartet conformations that 
selectively bind to specific and different epitopes of human α-thrombin [10]. TBA1 is a 15-mer DNA 
aptamer which binds exosite I of thrombin (Fibrinogen Binding Site) with nanomolar affinity [11,12], 
while TBA2 is a 29-mer DNA aptamer binding to exosite II of thrombin (Heparin Binding Domain) 
with subnanomolar affinity [10]. This distinct recognition pattern allows their use in tandem, since a 
ternary complex could possibly be formed by simultaneous recognition of thrombin as demonstrated 
by several groups employing different formats and detection methods [13-15]. The paper by Huang et al., 
in particular, reports a sandwich assay based on the two above mentioned aptamers for the detection of 
thrombin by time-resolved fluorescence [13]. In this case the sensing aptamer was   
conjugated via glutaraldehyde to a bifunctional lantanide complex, so that the signal by the   
europium-phenantroline-aptamer allowed for a very sensitive and specific detection of the protein. As 
underlined by these authors, care must be taken when covalently binding bulky fluorophores to 
aptamers, since an altered folding may result leading to a significant loss of affinity and specificity for 
the original target.  
To investigate whether post-SELEX chemical modifications introduced in aptamers would affect 
thrombin recognition prior to the development of a Sandwich Aptamer Microarray (SAM) system, we 
adopted these two aptamers and human thrombin as a model system, with the aim of recognizing in 
solution by a simple gel electrophoresis method any perturbation in the complex formation before the 
solid phase development. Following the indications of the solution studies, we adopted the SAM 
system, depicted in Figure 1, making use of laser scanning for the fluorescent detection of the 
thrombin-aptamer sandwich on the microarray.  
Figure 1. Representation of the Sandwich Aptamer Microarray (SAM) for thrombin 
detection performed following the two-steps (a) and the one-step (b) procedure. TBA1, 
anchored on the glass slide, is used as capture layer for thrombin. Fluorescently labelled 
TBA2 is used as detection layer. Modification on TBA1 was the introduction of 5’-NH2 
group for aptamer anchorage on slide surface plus a polyT spacer for accessibility of the  
G-quadruplex to thrombin. Modification on TBA2 was the 5’-conjugation with the 
fluorescent label Cy5 for detection of the fluorescence signal by a laser scanner.  
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The chemical modifications introduced in the capture aptamer TBA1 were: a 5’-NH2 group, needed 
for aptamer anchorage on slide surface and a polyT spacer also introduced at the 5’-end for making the 
G-4 motif of the anchored aptamer more accessible to the target protein, as indicated by the work of 
Lao et al. [16]. In the case of the secondary (sensing) aptamer (TBA2) a fluorescent dye, namely Cy5, 
was directly conjugated to the 5’-end of the oligonucleotide.  
The analysis in solution on the complexes formation between human thrombin and the modified 
aptamers was performed on native polyacrylamide gels by Electrophoretic Mobility Shift Assay 
(EMSA), also referred as gel shift assay, and the verification of the sandwich complex formation in 
solution by a Supershift Assay, incubating simultaneously the two aptamers with the target protein. 
The validated system was finally applied to the solid phase using an appropriate control and two 
different protocols for detection. The results obtained in the microarray are positive and consistent with 
the results obtained by the analysis in solution, and constitute the proof of principle of our approach of 
validating in solution the effects of chemical modification of aptamers prior or along the development 
of the solid phase.  
2. Experimental Section 
2.1. Aptamer and Thrombin Solutions 
The sequence of the unmodified 15-mer TBA1 [11] was: 5’-GGT TGG TGT GGT TGG-3’. TBA1 
was used in its unmodified form as control; to allow immobilization on solid phase, a 5’-amino 
modification (TBA1-NH2) and a 5’-amino modification plus a polyT(12) tail as spacer [reported as 
TBA1(12T)NH2] were also synthesized. The sequence of the unmodified 29-mer TBA2 control 
(TBA2) [10] was: 5’-AGT CCG TGG TAG GGC AGG TTG GGG TGA CT-3’. TBA2 was used as  
5’-Cy5 labeled (TBA2Cy5) to allow detection. As negative control in the Sandwich Aptamer 
Microarray we used an aptamer (OTA) that binds with high affinity and specificity to 
ochratoxin A [17]; the sequence of 5’-amino modified OTA to allow the binding on the slide was:  
5’-NH2-GAT CGG GTG TGG GTG GCG TAA AGG GAG CAT CGG ACA-3’. All the aptamers 
were purchased from IDT Integrated DNA Technologies (Munich, Germany) and stored at −20 °C in 
TE (10mM Tris-HCl, 1mM EDTA) pH 8.0. Human α-thrombin (T1063) was purchased from   
Sigma-Aldrich (St. Louis, MO, USA), dissolved in deionized purified (MilliQ) water, aliquoted and 
stored as recommended by the supplier. 
2.2. EMSA (Electrophoresis Mobility Shift Assay) Analysis for Binary Complexes 
The binding of each aptamer to the protein target in solution was analyzed by EMSA. Prior to 
incubation with thrombin, all the aptamer samples (oligonucleotide 10 µM in presence of KCl   
100 mM) were denatured at 95 °C for 5 minutes and the samples were left to cool to room temperature 
(slow annealing). Each folded aptamer (1 µM) was then incubated with increasing concentrations 
(from 0 to 12 µM) of human thrombin in a total volume of 20 μL, at 25 °C for 30 min. After incubation, 
free aptamer and thrombin-aptamer complexes were resolved by 12% non-denaturing polyacrylamide 
gels containing 1X TBE buffer (Tris-HCl 89 mM, borate 89 mM, EDTA 2mM) and KCl 10 mM. 
Aptamers on the gels were stained with the fluorescent DNA binding dye SybrGreen II
® (Invitrogen) Sensors 2011, 11                  
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that preferentially binds to single-stranded DNA and emits fluorescence (λexc = 488 nm; λem = 522 nm) 
when in complex with DNA. Fluorescence in gel systems was detected on a Geliance 600 Imaging 
System (PerkinElmer). 
2.3. Supershift Assays for Ternary Complexes 
To verify the sandwich formation in solution a Supershift Assay was performed: both pairs of 
folded aptamers (each 1 µM) were incubated simultaneously with the protein (5 µM) in the Binding 
Buffer (Tris 20 mM, KCl 5 mM, NaCl 140 mM, MgCl2 1 mM, pH 7.5) in a total volume of 20 µL, at 
25 °C for 30 min. After incubation, free aptamers and thrombin-aptamers complexes were resolved by 
12% non-denaturing polyacrylamide gels containing 1X TBE buffer (Tris-HCl 89 mM, borate 89 mM, 
EDTA 2mM) and KCl 10 mM. Aptamers on the gels were stained also in this case with the fluorescent 
DNA binding dye SybrGreen II
® (Invitrogen) that preferentially binds to single-stranded DNA and 
emits fluorescence (λexc = 488 nm; λem = 522 nm) when in complex with DNA. Fluorescence in gel 
systems was detected on a Geliance 600 Imaging System (Perkin Elmer). Relative mobilities of each 
band were calculated as Rf, i.e., the ratio between the distance traveled by the sample (band) divided 
by the distance traveled by the marking dye (bromophenol blue) in the gel. 
2.4. Aptamer Preparation for SAM 
In the aptamer arrays TBA1 was used as capture layer for thrombin. A sequence that binds with 
high affinity and specificity to ochratoxin A, was anchored as negative control on a distinct spot on the 
slide surface parallel to TBA1’s spots. Prior to immobilization on the glass slide, TBA1 and OTA  
(80 µM in presence of KCl 100 mM) were denatured at 95 °C for 5 minutes and then left to cool to 
room temperature. This folding step ensures that they assume the G-quadruplex structure, responsible 
for thrombin binding. Folded aptamers were then diluted in the Printing Buffer 1.5X (Printing Buffer 
6X: sodium phosphate300 mM, 0.02% Triton pH 8.5) to a final concentration of 20 µM. These probes 
were loaded into micro-plates and submitted to the Spotter Arrayer (Versarray Chip Writer Pro 
System, BioRad) for slide printing.  
2.5. Printing of Aptamer Microarrays 
E-surf LifeLine slides (25 mm × 75 mm, LifeLineLab, Pomezia, Italy) were used for   
printing: these slides are obtained by adsorption on glass of a hydrophilic polymer containing   
N,N-acryloyloxysuccinimide (NAS), allowing binding to the 5’-amino modified DNA aptamers   
TBA1-NH2 and OTA. To improve capture-protein efficiency, we anchored on the glass slide also the 
TBA1 5’-amino modified with a polyT (12T) spacer at the 5’-end. In this way the G-quadruplex 
structure of TBA1 can fold correctly to recognize the protein target. 
The same spot scheme shown in Table 1 was printed 12 times (12 sub-arrays) on the same slide: 
capture aptamers [TBA1-NH2 or TBA1(12T)NH2] and OTA control were printed in six spots to ensure 
the reproducibility of the system. Slides were printed by the Spotter Arrayer instrument, using Telechem 
SMP3 microspotting pins. Printed slides were incubated overnight in a 75% humidity incubation 
chamber, blocked at 30 °C in Blocking Solution (0.1 M Tris, 50 mM ethanolamine), washed at 30 °C Sensors 2011, 11                  
 
 
9431
in Washing Solution (4X SSC, 0.1% SDS) and finally washed in MilliQ H2O, spin-dried and stored 
properly until usage. Each slide has the possibility to test up to 12 samples at once, since each   
sub-array can be physically isolated from the others by the Corning Microarray Hybridization Chamber 
(Corning, NY, USA) during the hybridization phase of the experiment. This approach ensures to 
hybridize up to 12 samples at the same time and nevertheless to minimize array variation resulting 
from minor fluctuation of external parameters. 
Table 1. Scheme of the printed glass slide. 
 
2.6. Protein Labeling 
The AlexaFluor
®555 monoreactive Succinimidyl Esters (Invitrogen), dissolved in anhydrous 
dimethyl sulfoxide (DMSO) solvent was used to label thrombin samples. Prior to labeling, thrombin 
and AlexaFluor
® 555 were first diluted to proper reaction concentrations in MilliQ H2O. The labeling 
reaction was done mixing thrombin samples with the AlexaFluor
®555 NHS esters reagent in the 
Coupling Buffer (sodium carbonate 0.1 M, pH 9.4); the optimal dye to protein ratio was 2; the reaction 
was incubated 2 h at 4 °C. After this time, glycine was added to the mixture in order to block the free 
unreacted AlexaFluor
®555 NHS esters. The labeled protein samples were kept in the dark at 4 °C, and 
all samples were used within a week. 
2.7. Detection Layer Preparation 
The fluorescently labeled TBA2 (TBA2Cy5) was used as secondary aptamer for detecting thrombin 
captured by the primary aptamer (TBA1). TBA2Cy5 (10 µM in KCl 100 mM) was denatured at 95 °C 
for 5 minutes and then left to cool to room temperature in order to assume G-quadruplex structure, 
which is essential for recognition of the heparin binding domain of thrombin. 
2.8. Sandwich Aptamer Microarray Assays 
The printed aptamer microarrays prepared as detailed above were immersed just before analysis in 
the Binding Buffer 1X (Tris 20 mM, KCl 5 mM, NaCl 140 mM, MgCl2 1 mM, pH 7.5) at room 
temperature for 15 min.  
The sandwich aptamer microarrays were performed with two procedures, i.e., analyzing the 
sandwich formation on surface either in one step or in a two steps protocol (see Figure 1). The one 
step-procedure consisted in the pre-incubation of thrombin with the fluorescently labelled aptamer Sensors 2011, 11                  
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(TBA2Cy5) in solution in the Binding Buffer, at 25 °C for 30 min. The pre-formed complex thus 
obtained was then incubated in the microarray at 25 °C for 30 min. The two steps-procedure consists 
of the incubation in the microarray of thrombin diluted in the Binding Buffer at 25 °C for 30 min, 
followed by the incubation with the fluorescently labelled secondary aptamer (TBA2Cy5) diluted in 
the Binding Buffer, at 25 °C for further 30 min. Finally, the aptamer microarrays were carefully rinsed 
with the PBS Buffer (phosphate 10 mM, NaCl 137 mM, KCl 3 mM, pH 7.4), washed three times with 
PBS at room temperature to remove the unbound proteins and rapidly rinsed in MilliQ H2O before 
spin-drying, ready to be scanned. 
2.9. Slides Scanning and Data Analysis 
Spin-dried aptamer arrays were scanned using Genepix 4000B laser scanner (Molecular Devices) 
and the Gene Pix Pro software using both 532 nm and 635 nm wavelength and PTM gain 550 for both 
channels (Power 33). Fluorescent spot intensities were quantified using the Gene Pix Pro software after 
normalizing the data by subtracting local background from the recorded spot intensities. For each set 
of six spots median and standard deviation were calculated. 
3. Results and Discussion 
3.1. Analysis and Optimization of TBA1-Thrombin Interaction 
3.1.1. Role of K
+ Ions 
The DNA 15-mer TBA1 recognizes specifically the Fibrinogen Binding Domain (FBD) of thrombin 
by adopting the four-stranded DNA structure known as G-quadruplex (G-4) [11,18]. Monovalent 
cations, in particular K
+ and Na
+, are essential to form and stabilize G-4 structures [19], with K
+ ions 
favoring the recognition of thrombin to immobilized aptamers at temperatures higher than 25 °C [20]. 
For TBA1 and TBA2 folding of TBA1 into G-quartets in solution is favored by the presence of K
+ 
ions, being 5.8 mM the minimal concentrations required for TBA1, while TBA2 requires a slightly 
higher ion concentration [21]. Therefore, we investigated the effect of potassium ions 10 mM on the 
binding of TBA1 and thrombin in our conditions to decide whether it would be a component of the 
buffer system. TBA1 was denatured, folded and incubated with thrombin (up to 12 µM) in the 
presence or absence of KCl. Complex formation was analyzed by EMSA. Free and complexed 
aptamers were detected in the gel by staining with SybrGreen II. As shown in Figure 2(a), the band 
corresponding to free TBA1 shifts up in the gel starting from 1:1 TBA1/thrombin ratio, consistent with 
the lower mobility of the TBA1-thrombin complex. At the same time, the free TBA1 band disappears. 
The presence of the upper band with lower electrophoretical mobility indicates that TBA1 is 
complexed with the target protein under these conditions, i.e., in the presence of K
+ ions. Figure 2(b) 
shows the result of the same experiment performed in the absence of K
+ ions at all steps (folding, 
incubation with thrombin and analysis by EMSA). We can observe that TBA1 binds thrombin but with 
reduced affinity, since the shift of TBA1 band appears at a higher TBA1/thrombin ratio (1:2). 
Although thrombin itself is known to act as a molecular chaperone promoting the G-quadruplex 
formation in the aptamer [22], the presence of K
+ cations favours G-4 formation and facilitates TBA1-Sensors 2011, 11                  
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thrombin binding. Higher concentrations of potassium ions were also analyzed (up to 100 mM), but the 
high salt in the gel and in the running buffer impairs EMSA assay. For these reasons we considered as 
optimal binding conditions the presence of K
+ ions and 10 mM KCl was included in our systems. 
Figure 2. Electrophoretic Mobility Shift Assay (EMSA) of unmodified TBA1 and 
thrombin in presence (a) and in absence of Potassium (b). TBA1 was incubated with the 
protein under the conditions described. We have indicated in the figure the respective 
TBA1 and thrombin concentrations. A control reaction without thrombin was performed in 
all experiments. KCl was added to the polyacrilamide gel and to the running buffer. 
Binding reactions were applied on a 12% non-denaturing PAA gel containing 1X TBE 
buffer and KCl 10 mM. The mobility of free and complexed aptamers, stained by 
SybrGreen II®, was detected using the Geliance 600 Imaging System. 
 
3.1.2. Role of TBA1 Modifications 
To immobilize TBA1, the capture layer in our aptamer-based microarray, 5’-amino modification of 
the oligonucleotide was required for aptamer anchorage on the glass slides. Therefore, we investigated 
in solution the effect of this modification on thrombin binding: folded TBA1-NH2 (1 µM) was 
incubated with increasing concentrations (0, 0.001, 0.01, 0.1, 1, 2, 5 and 12 µM) of human thrombin 
following the procedure described above for unmodified TBA1. Figure 3(a) shows that, starting from a 
1:1 aptamer to thrombin ratio, the band of the free aptamer gradually disappears and at the same time 
the band with lower mobility corresponding to TBA1-NH2-thrombin complex appears. Hence, 
comparing these results with what seen for unmodified TBA1 [Figure 2(a)], the 5’-amino modification 
does not impair the TBA1-thrombin binding. To evaluate the effect of the polyT spacer added at the 
5’-end of the oligonucleotide, the same experiment was performed using TBA1(12T)NH2: the results 
are reported in Figure 3(b).  
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Figure 3. Electrophoretic Mobility Shift Assay (EMSA) of TBA1-NH2 with thrombin (a) 
and of TBA1(12T)NH2 with thrombin (b). TBA1-NH2 and TBA(12T)NH2 were separately 
incubated with the protein under the conditions described. We have indicated in the figure 
the respective aptamer and thrombin concentrations. A control reaction without thrombin 
was performed in all experiments. Binding reactions were applied on a 12%   
non-denaturing PAA gel containing 1X TBE buffer and KCl 10mM. The mobility of free 
and complexed aptamers, stained by SybrGreen II®, was detected using the Geliance   
600 Imaging System. 
 
From a 1:1 aptamer/thrombin ratio the band of the free aptamer shifts up in the gel in bands that are 
slightly smeared compared to those of unmodified aptamer-thrombin [compare Figure 3 with Figure 2(a)]. 
We can conclude that, although more than one complex seems to be present relative to the unmodified 
control, suggesting the possible presence of different folding equilibria, the addition of the polyT (12T) 
spacer at the 5’-end of the 15 nucleotides capture aptamer TBA1 does not inhibit the recognition of the 
protein in solution, in agreement with what reported in solid phase for the recognition of Cy-labeled 
thrombin with the modified aptamer [16]. 
3.2. TBA2-Thrombin Interaction in Solution  
3.2.1. Evaluation of Labeling with Cy5 Dye 
The 29-mer DNA TBA2, planned to be used for fluorescence detection in our aptamer-based 
microarray, has to bear important chemical modifications at its 5’ end: to rule out any possible 
interference of the aromatic systems of fluorescent dyes on the folding and on the recognition of the 
aptamer with the target, thrombin binding by the unmodified TBA2 was compared to that exhibited by 
TBA2 fluorescently labeled at the 5’-end with the red light emitter Cy5 (TBA2Cy5). The gel shifts of 
the unmodified and modified aptamers are shown in Figure 4. Sensors 2011, 11                  
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Figure 4. Electrophoretic Mobility Shift Assay (EMSA) of unmodified TBA2 with 
thrombin  (a) and TBA2Cy5 with thrombin (b). Each aptamer was incubated with the 
protein under the conditions described. We have indicated in the figure the respective 
aptamer and thrombin concentrations. A control reaction without thrombin was performed 
in all experiments. Binding reactions were applied on a 12% non-denaturing PAA gel 
containing 1X TBE buffer and KCl 10 mM. The mobility of free and complexed aptamers, 
stained by SybrGreen II
®(a,b) was detected using the Geliance 600 Imaging System. 
 
 
The unmodified TBA2 in KCl 10 mM folds in G-quadruplex, as reported by CD titrations [21], and 
binds thrombin from TBA2/thrombin ratio 1:1 [Figure 4(a)]: the band corresponding to TBA2 shifts up 
and new bands with lower mobility, representing the TBA2-thrombin complex, appear in the upper 
part of the gel, as expected. An evident gel shift at same ratio aptamer/protein was obtained even when 
the 5’-Cy5 labeled TBA2 was analyzed [Figure 4(b)]. The 5’-labeling of TBA2 with Cy5 evidently 
influences the overall hydrodynamic volume of the complex with thrombin, as seen by the appearance 
of bands of relative lower mobilities [Figure 4(b)] compared to the complex with unlabeled aptamer 
controls [Figure 4(a)]. The planar and hydrophobic surfaces individuated by the fluorophore and, 
possibly, also the structure(s) of the binary complex(es) with thrombin are affected: at the highest 
protein/oligo ratio the modified aptamer forms complexes with even lower electrophoretic mobilities, 
possibly consistent with the formation of aptamer/protein complexes with a different stoichiometry or 
a different shape. These observations are in line with literature data on the strict structural 
requirements of TBA2 for correct folding and target binding [23]. However, we can observe that the 
presence of the labeling dye Cy5 conjugated to the aptamer allows thrombin recognition, since the 
binary complex formation is not abolished. The solution experiments point to the requirement of 
careful handling of the detection aptamer when adapting the solution studies to the solid phase: correct 
structuring of the labeled TBA2 must be ensured by denaturing/folding protocols prior to its use to 
ensure thrombin recognition. 
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3.3. Supershift Assay: Optimization of TBA1-Thr-TBA2 Interaction 
After having completed the studies of thrombin binding for each set of modified aptamers, we 
verified the formation of the ternary complex in solution. The Supershift Assay using the aptamers 
with the modifications needed for solid phase will indicate the feasibility of the sandwich system in the 
planned microarray and will constitute the proof of principle of our approach. 
The Supershift Assay was performed with TBA1(12T)NH2 as capture layer and TBA2Cy5 as 
detection layer. The primary aptamer and the secondary aptamer were folded in KCl, mixed and   
then incubated with thrombin(s) in the Binding Buffer at 25 °C for 30 min. Human thrombin and 
Alexa555-labeled human thrombin were used to verify ternary complex formation. After incubation, 
free aptamer and thrombin-aptamer complexes were resolved by 12% non-denaturing polyacrylamide 
gel containing KCl. Free aptamers and the binary complex of each aptamer with thrombin were loaded 
in the gel as controls. 
The results of this experiment employing different detection systems are reported in Figure 5. 
Figure 5(a) shows the image detected analyzing green light emission without any gel staining: the 
bands detected correspond to thrombin labelled with Alexa555. Figure 5(b) shows the result of the 
supershift assay using Coomassie Blue to visualize the position of unlabeled thrombin and Alexa555 
labeled thrombin, either alone or complexed with aptamers. A third method of staining with the 
fluorescent intercalator SybrGreen II (not shown), allows the detection of the aptamer bands in the gel.  
Figure 5. Electrophoretic Mobility Supershift Assay (EMSA) of TBA1(12T)NH2 + 
thrombin + TBA2Cy5: detection of Alexa555-labeled thrombin (a); detection of thrombin 
with Coomassie Blue staining (b). Each aptamer was incubated separately or simultaneously 
with the unmodified and fluorescently labeled protein under the conditions described. We 
have indicated in the figure the respective aptamer and thrombin concentrations. A reaction 
control without thrombin was performed for each aptamer; other reaction controls were the 
unmodified and fluorescently labelled thrombin incubated without any aptamer. Binding 
reactions were applied on a 12% non-denaturing PAA gel containing 1X TBE buffer and 
KCl 10 mM. The mobility of free and complexed aptamers was detected using the Geliance 
600 Imaging System. 
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Thrombin has an almost neutral pI [20] and its mobility is limited in the native gel system employed 
(Tris borate buffer, pH 8.3). It is clearly evident in Figure 5(b) that Alexa labeling changes the 
mobility of the protein: Alexa-thrombin moves faster compared to unmodified thrombin. Although the 
molecular structure of Alexa555
® is not disclosed by the manufacturer, it possesses a negative charge 
(information provided by Invitrogen) that alters the charge profile of the protein, and is responsible for 
the higher mobility of the protein in the native polyacrylamide gel system used.  
The band of each free aptamer shifts up in presence of fluorescently labeled or unmodified 
thrombin, due to the higher molecular weight aptamer-protein complex formation, as verified in the 
previous experiments. When in complex with both aptamers thrombin forms a ternary complex 
verified by the appearance of the supershift band with lower mobility than the binary complex band 
[Figure 5(b)]. This is clearly evident in the case of unmodified thrombin, and it is also verified for 
Alexa-thrombin. The relative mobilities of the complexes, calculated as Rf for each band, are 
summarized in Table 2.  
Table 2. Relative mobilities (Rf) of binary and ternary complexes. 
  +TBA1(12T)NH2  +TBA2Cy5  +TBA1(12T)NH2+TBA2Cy5     
Protein  Thr  Alexa555-Thr  Thr  Alexa555-Thr Thr  Alexa555-Thr  Thr  Alexa555-Thr
Rf  0.05  0.09  0.05  0.09  0.04  0.08  0.07  0.09 
Alexa-labeled protein moves faster than the unlabeled thrombin (Rf: 0.09 vs. 0.07); in the case of 
binary complexes with human thrombin the bands are shifted up from the protein alone (to 0.05 for 
both capture and detection aptamer), and are further shifted (to 0.04) when all the system players are in 
a ternary complex. With Alexa-thrombin the mobilities of the binary complexes approximate that of 
the labeled protein (Rf = 0.09). However, when both aptamers are incubated with Alexa-thrombin the 
ternary complex band mobility is retarded to an Rf of 0.08. Therefore, in the context of the system 
corresponding to the solid phase sandwich the solution study indicates that the ternary complexes are 
formed in all cases investigated and the system can be applied to the solid phase. 
3.4. Sandwich Aptamer Microarray Assays: Optimization of the Aptamer-Thrombin Sandwich Protocol 
The sandwich system with the modified aptamers analyzed in solution was finally applied to the 
microarray system, i.e., in solid phase. The SAM was performed with the same system shown in 
Figure 5, i.e., using TBA1(12T)NH2 as capture layer for thrombin and the fluorescently labeled 
TBA2Cy5 as detection layer. In this case sandwich formation is detected by the red fluorescence of 
TBA2Cy5.  
Alexa-labelled thrombin was also used as control to further verify the sandwich formation by the 
yellow fluorescence resulting from the co-localization of green (Alexa conjugated to the protein) and 
red (Cy conjugated to the oligonucleotide) fluorophores. Two different protocols were tested for the 
sandwich formation on surface: a one-step procedure by deposing on the capture layer thrombin(s)  
pre-incubated with the detection aptamer (chambers 1 and 2) and a two-steps procedure deposing 
thrombin on the capture layer, followed by a final deposition of the detection layer. The slides 
carefully rinsed with the PBS Buffer and MilliQ H2O were finally spin-dried and scanned. The Sensors 2011, 11                  
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samples (six spots for each sample) were prepared as shown schematically in Table 3; each sub-array 
was physically isolated from the others.  
Table 3. Schematic representation of the samples incubated in the SAM protocol. 
Sub-array  1  2  3  4 
Capture 
layer 
TBA1(12T)NH2  OTA  TBA1(12T)NH2  OTA  TBA1(12T)NH2  OTA  TBA1(12T)NH2  OTA 
Protein  Thr(0.5 μM) 
pre-complexed with 
TBA2Cy5 (1 μM) 
Alexa555-Thr (0.5 μM) 
pre-complexed with 
TBA2Cy5 (1 μM) 
Thr (0.5 μM)  Alexa555-Thr (0.5 μM) 
Detection 
layer 
TBA2Cy5 (1 μM)  TBA2Cy5 (1 μM) 
Procedure  One-step  Two-steps 
The results of the SAM experiments are shown in Figure 6. 
Figure 6. Images of the slide after the Sandwich Aptamer Microarray (SAM). In each sub-
array TBA1(12T)NH2 was printed on the left, while OTA on the right. The fluorophore 
Cy5 emitted red light, while Alexa555 emitted green light. For this reason red fluorescence 
represents TBA2Cy5 and green fluorescence represents labeled thrombin. In chambers 2 
and 4, in which labeled thrombin was incubated, the fluorescence was detected with two 
different contrasts to reveal first red light and then green light: yellow spots indicate the 
simultaneously localization of the two fluorophores. 
 
In chambers 1 and 2 the red spots (TBA2Cy5) in correspondence of the selection aptamer 
TBA1(12T)NH2 anchored on the glass slide reveal that the sandwich was formed with high specificity 
for the thrombin aptamer: the detection of the Cy5 labeled aptamer is reproducible across the six spots 
of each sub-array. The recognition is also specific: no signal is detected for the negative control OTA. 
SAM is formed with thrombin and also with Alexa-labeled thrombin, consistently with the solution 
studies: in the sub-arrays 2, Alexa-labeled thrombin allows a further control for thrombin presence in 
the sandwich by the yellow fluorescence resulting from the simultaneous presence of green 
fluorescence (Alexa555-thrombin) and red fluorescence (TBA2Cy5). The absence of unexpected 
hybridization between TBA1 and TBA2Cy5 and the formation of a specific complex between   
Alexa-thrombin and immobilized TBA1 were also verified independently (not shown). Sensors 2011, 11                  
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The one-step protocol is more efficient than the two step procedure: the detection of the sandwich is 
sharp and specific in chambers 1 and 2 compared with chambers 3 and 4. In chamber 3 the signal 
obtained is weak, while chamber 4 (Alexa-labeled protein) exhibits a higher background and lower 
selectivity at this ionic strength. As indicated by the solution studies, the recognition of TBACy5 with 
human thrombin seems to be the critical step in the development of the best protocol for the solid 
phase system. The one-step protocols ensures enough time to the modified detection aptamer for the 
formation of the correct binary complex able to expose the protein epitopes recognized by the 
immobilized capture aptamer. The presence of the fluorescent dye conjugated to the protein has also a 
negative effect, possibly influencing the pattern mode of recognition aptamer-thrombin, reflected in 
the loss of specificity of binding. The microarray system protocol of chamber 1 is a successful 
application of the aptamer sandwich devised, and further optimization of the solid phase microarray 
system is in process.  
4. Conclusions 
Several sandwich systems for thrombin detection employing aptamers have been recently reported: 
among them, a very sensitive device described the use of gold nanoparticles detected by ICP-mass 
spectrometry [15]. Electrochemical detection was employed with gold-immobilized aptamers in a 
sandwich system using a secondary aptamer labeled with quantum dots [24], or by using a split 
aptamer approach [25]. Sensitive systems allowing to re-use the aptasensor were developed based on 
fluorescence detection, either relying on quantum dots [14] or on europium-phenanthroline chelates [13].  
The present study reports the development of a Sandwich Aptamer Microarray (SAM) for human 
thrombin detection using DNA aptamers modified at the 5’-end for the application to the surface of 
glass slides and for fluorescence detection. An extensive analysis, optimization and validation of 
binary and ternary complexes formation between the modified aptamers and thrombin in solution was 
followed by the verification of the aptamer sandwich formation in solid phase. Our results add 
information of the effects of modifying aptamers for microarray applications: the 5’-modifications to 
TBA1 have a minimal but observable effect on thrombin recognition in solution. In solid phase the 
aptamer orientation through the polyT spacer allows for the correct presentation to the protein, in 
agreement with the results obtained by other authors analyzing in solid phase the binding of 5’-end 
modified aptamers to Cy-labeled thrombin [16]. Differently from the co-printing system adopted by 
these authors, we resorted to a classical sandwich for detecting thrombin. The labeling of TBA2 with 
the fluorophore Cy5 influences the complex formation with thrombin, as cautioned when reporting a 
mixed antibody-aptamer format [23]. Our results however show that, overall, the binding to the 
macromolecular target is preserved in solution when TBA2 is conjugated to Cy5, that was therefore 
adopted for fluorescent detection. Complex formation was verified analyzing the glass slides by a 
microarray laser scanner, and correct sandwich formation was confirmed by the fluorescence signals of 
the sandwich (Figure 6). The microarray for thrombin detection indeed results specific and efficient, 
therefore representing a potential tool for diagnostic application. The SAM system described here will 
be further characterized for the limit of detection and optimized for the best incubation time, 
temperature and presence of protein contaminants by biological samples, to be developed as a simple Sensors 2011, 11                  
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and sensitive thrombin diagnostic tool with comparable sensitivity and specificity exhibited by known 
systems [13-16,24,25]. 
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